PYRGFOTCPharmaceutical PreparationsFiscal year ends December 31
PyroGenesis Canada Inc.
Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 40-F on Mar 31, 2023
$0.16+0.00 (+2.73%)
Close on Oct 19, 2026
Margins
Share of revenue, fiscal years 2018 to 2022
Gross margin
42.8%
Operating margin
-122.0%
Growth rates
Compound annual growth to fiscal 2022
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -38.8% | +58.1% | – | – | |
| Gross profit | -34.5% | +84.4% | – | – |
Returns and balance sheet
5 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2018 | FY2022 | Trend |
|---|---|---|---|---|
| Current ratio | – | – | 1.06 | |
| Interest coverage | – | – | -260.4× | |
| Capex to revenue | – | – | 2.1% | |
| Diluted shares | – | – | 171M |
Cash use needs five years of cash flow figures
PyroGenesis Canada does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2022 against fiscal 2021
1of 6 tests passed in fiscal 2022. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero-C$11.13M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income-C$11.13M vs –
- Less leverageLong-term debt to assets fell0.2% → 0.7%
- Better liquidityCurrent ratio rose1.57 → 1.06
- No dilutionShare count did not rise167M → 171M
- Gross margin improvedGross margin up on the prior year40.01% → 42.83%
- More efficientAsset turnover rose0.42 → 0.27